Small intestine carcinoma, also known as small bowel cancer, is a rare but serious disease that requires careful management and personalized treatment approaches. While it represents only 3% of gastrointestinal cancers, understanding the available treatment options—from established surgical methods to experimental therapies being tested in clinical trials—can make a significant difference in patient outcomes and quality of life.

How Treatment Decisions Are Made for Small Intestine Carcinoma

When someone is diagnosed with small intestine carcinoma, doctors face the challenge of creating a treatment plan that fits the individual’s specific situation. The main goal of treatment varies depending on how advanced the cancer is: for some patients, the aim is to remove the cancer completely and prevent it from coming back; for others, it focuses on controlling symptoms, slowing cancer growth, and maintaining the best possible quality of life.

Treatment decisions are never one-size-fits-all. Doctors consider multiple factors before recommending a specific approach. The stage of the cancer—meaning how large it is and whether it has spread beyond the small intestine—plays a crucial role. The exact location within the small intestine matters too, as tumors in the duodenum (the first part near the stomach) may require different surgical techniques than those in the ileum (the last part near the large intestine). Additionally, doctors evaluate the patient’s overall health, nutritional status, age, and personal preferences. Someone with other serious medical conditions might need a gentler approach than someone who is otherwise healthy.^[11]

There are standard treatments that medical societies have approved and recommended based on years of research and clinical experience. These form the backbone of care for most patients. However, there is also ongoing research into new therapies through clinical trials. These experimental treatments may offer hope for patients whose cancer doesn’t respond well to standard approaches or who want to contribute to advancing medical knowledge.^[3]

Standard Treatment Approaches

Surgery: The Primary Treatment

Surgery is the most common and often the most effective treatment for small intestine carcinoma, especially when the cancer has not spread to other parts of the body. The type of surgical procedure depends on where the tumor is located in the small intestine. The most common operation is called wide excision, where the surgeon removes the cancerous section of the intestine along with a margin of healthy tissue around it to ensure all cancer cells are eliminated. The nearby lymph nodes—small bean-shaped structures that filter fluids and can trap cancer cells—are also removed and examined under a microscope.^[17]

For tumors located in the duodenum, particularly near where it connects to the stomach, a more complex operation called pancreaticoduodenectomy may be necessary. This procedure removes not only part of the small intestine but also portions of the pancreas, gallbladder, and sometimes part of the stomach. While this sounds extensive, it is sometimes the only way to completely remove cancer in this location.^[17]

After removing the cancerous section, surgeons usually reconnect the remaining healthy parts of the intestine so that digestion can continue normally. However, in some cases, this reconnection isn’t immediately possible or carries too high a risk of complications. In such situations, doctors may create an ileostomy—an opening in the abdomen through which waste can leave the body and be collected in a special bag worn outside the body. While adjusting to an ileostomy can be emotionally and practically challenging, many people learn to manage it successfully and maintain good quality of life.^[17]

Sometimes cancer causes a complete blockage of the intestine, preventing digested food and waste from passing through. This is called bowel obstruction and causes severe symptoms like intense abdominal pain, vomiting, and inability to pass stool. When this happens, doctors may perform emergency surgery to remove the blocked section, or they might insert a stent—a small tube that holds the intestine open and allows waste to pass through. This can provide quick relief from symptoms even if it doesn’t treat the cancer itself.^[17]

Chemotherapy: Using Drugs to Fight Cancer

Chemotherapy uses powerful medicines to destroy cancer cells throughout the body. These drugs travel through the bloodstream, reaching cancer cells wherever they may be—not just in the small intestine but also in lymph nodes or distant organs if the cancer has spread. Chemotherapy is sometimes given after surgery to kill any remaining cancer cells that might be too small to see, reducing the risk that cancer will return. This is called adjuvant chemotherapy. For some patients with duodenal tumors, doctors may recommend adjuvant chemotherapy, though more research is needed to fully understand its benefits.^[11]

When cancer has spread to other parts of the body or cannot be completely removed by surgery, chemotherapy becomes the primary treatment. It can help shrink tumors, slow cancer growth, and reduce symptoms like pain or bowel obstruction. Several chemotherapy drugs are used for small intestine carcinoma. Common regimens include fluorouracil (also called 5-FU), often combined with folinic acid to make it more effective. Other combinations include FOLFOX (folinic acid, fluorouracil, and oxaliplatin), CAPOX (oxaliplatin and capecitabine), and FOLFIRI (folinic acid, fluorouracil, and irinotecan).^[11]

Chemotherapy affects not only cancer cells but also some healthy cells that divide rapidly, such as those in the hair follicles, digestive tract lining, and bone marrow. This causes side effects that vary depending on which drugs are used and how a person’s body responds. Common side effects include nausea and vomiting, diarrhea, fatigue, hair loss, increased risk of infections (because white blood cells are reduced), and changes in sensation in hands and feet (called peripheral neuropathy). Most side effects are temporary and improve after treatment ends, and doctors can prescribe medications to help manage them.^[11]

Radiation Therapy: Targeting Cancer with High-Energy Rays

Radiation therapy uses high-energy rays or particles to damage cancer cells’ DNA, preventing them from growing and dividing. While radiation therapy is not commonly used for small intestine carcinoma, it has specific roles in treatment. It may be used before surgery to shrink a tumor, making it easier to remove completely. It can also help control symptoms when cancer has spread to other parts of the body, such as bones or the liver, where it might be causing pain or other problems.^[12]

Radiation therapy for small intestine cancer is typically delivered from outside the body using a machine that aims the radiation beam precisely at the tumor. Treatment is usually given in multiple sessions over several weeks. Side effects depend on which part of the body receives radiation but may include fatigue, skin changes in the treated area (similar to sunburn), nausea, and diarrhea. These effects usually improve gradually after treatment is completed.^[17]

Targeted Therapy: Precision Medicine Approaches

Targeted therapy is a type of treatment that attacks specific molecules or pathways that cancer cells use to grow and survive. Unlike chemotherapy, which affects all rapidly dividing cells, targeted therapy is designed to interfere more specifically with cancer cells, potentially causing fewer side effects. For small intestine carcinoma that cannot be surgically removed or that has spread, targeted therapy may be an option in certain cases. However, these treatments are not suitable for all patients—doctors typically perform special tests on the tumor tissue to determine whether specific targets are present.^[11]

Immunotherapy: Harnessing the Immune System

Immunotherapy is a treatment approach that helps the patient’s own immune system recognize and attack cancer cells. The immune system normally protects the body from infections and abnormal cells, but cancer cells can sometimes hide from immune detection. Immunotherapy drugs work by removing these hiding mechanisms, essentially taking the brakes off the immune system so it can do its job.

For small intestine carcinoma, immunotherapy may be offered to patients whose tumors have certain genetic characteristics or when the cancer has spread and other treatments haven’t worked. Like other treatments, immunotherapy can cause side effects, though they differ from chemotherapy side effects. Because the immune system becomes more active, it can sometimes attack healthy tissues, causing inflammation in various organs. Doctors carefully monitor patients receiving immunotherapy and can prescribe medications to control these effects.^[11]

Treatment Being Explored in Clinical Trials

While standard treatments work for many patients, researchers are constantly seeking better therapies that are more effective, cause fewer side effects, or work for cancers that have stopped responding to existing treatments. This research happens through clinical trials—carefully controlled studies where patients receive new treatments while being closely monitored by medical teams.

Clinical trials follow a structured process with different phases. Phase I trials focus primarily on safety—determining what dose of a new drug can be given safely and what side effects might occur. These trials usually involve small numbers of patients. Phase II trials test whether the treatment actually works against the cancer—does it shrink tumors or slow cancer growth? These trials involve more patients. Phase III trials compare the new treatment directly with current standard treatments to see if the new approach is better, involves larger groups of patients, and provides the strongest evidence for whether a treatment should become a new standard of care.^[3]

For small intestine carcinoma, researchers are investigating various innovative approaches. Some studies are testing new combinations of chemotherapy drugs or exploring whether existing drugs used for other types of cancer might also work for small intestine tumors. Because small intestine carcinoma shares some characteristics with colorectal cancer (cancer of the large intestine), treatments that work well for colorectal cancer are being studied to see if they also benefit patients with small intestine cancer.

Other clinical trials are examining newer targeted therapies that attack specific molecules involved in cancer growth. Scientists have identified various molecular pathways that cancer cells depend on, and drugs are being developed to block these pathways. For example, some trials are testing drugs that interfere with blood vessel formation around tumors—without a blood supply, tumors cannot grow. Other targeted therapies focus on blocking signals that tell cancer cells to divide or preventing them from repairing their own DNA damage.

Immunotherapy research for small intestine carcinoma is particularly exciting. Studies are examining drugs called checkpoint inhibitors, which help the immune system recognize cancer cells by blocking proteins that normally prevent immune attacks. Some trials are also exploring cancer vaccines—treatments that teach the immune system to recognize specific proteins on cancer cells—and adoptive cell therapies, where a patient’s own immune cells are collected, modified in the laboratory to better attack cancer, and then returned to the patient’s body.

Eligibility for clinical trials depends on many factors, including the type and stage of cancer, previous treatments received, overall health status, and specific characteristics of the tumor. Clinical trials are conducted at cancer centers and research hospitals in various locations, including the United States, Europe, and other regions. Patients interested in clinical trials should discuss this option with their healthcare team, who can help identify appropriate trials and explain the potential benefits and risks.^[3]

Most common treatment methods

• Surgery
  • Wide excision to remove the tumor along with surrounding healthy tissue and nearby lymph nodes
  • Pancreaticoduodenectomy for tumors in the duodenum, removing part of the pancreas, gallbladder, and sometimes stomach
  • Bowel obstruction relief through stent placement or surgical removal of blocked intestine sections
  • Ileostomy creation when intestinal reconnection isn’t immediately possible
• Chemotherapy
  • Fluorouracil (5-FU) combined with folinic acid to enhance effectiveness
  • FOLFOX regimen (folinic acid, fluorouracil, and oxaliplatin)
  • CAPOX regimen (oxaliplatin and capecitabine)
  • FOLFIRI regimen (folinic acid, fluorouracil, and irinotecan)
  • Adjuvant chemotherapy after surgery to reduce recurrence risk
  • Primary chemotherapy for unresectable or metastatic cancer
• Radiation Therapy
  • Pre-surgical radiation to shrink tumors
  • Symptom control for metastatic cancer, particularly for pain relief
  • External beam radiation delivered in multiple sessions
• Targeted Therapy
  • Drugs targeting specific molecular pathways in cancer cells
  • Treatment based on specific tumor characteristics identified through testing
  • Used for unresectable or metastatic disease in selected cases
• Immunotherapy
  • Checkpoint inhibitors that help immune system recognize cancer cells
  • Treatment for tumors with specific genetic characteristics
  • Option for metastatic disease when other treatments haven’t worked